Rett syndrome: Randomized controlled trial of L-carnitine

Journal of Child Neurology

Volumn 14, Issue 3, 1999, Pages 162-167

  Ellaway, Carolyn ^a,b   Williams, Katrina ^a,b   Leonard, Helen ^c   Higgins, Gwen ^a   Wilcken, Bridget ^a   Christodoulou, John ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; MALE; MITOCHONDRIAL ENERGY TRANSFER; MOTOR ACTIVITY; OUTCOMES RESEARCH; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETT SYNDROME; WELLBEING;

EID: 0033013097     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400306     Document Type: Article

References (20)

1. Clarke A: Rett syndrome. J Med Genet 1996;33:693-699.
2. Hagberg B, Hagberg G: Rett syndrome: Epidemiology and geographical variability. Eur Child Adolesc Psychiatry 1997;6(Suppl 1):5-7.
3. Leonard H, Bower C, English D: The prevalence and incidence of Rett syndrome in Australia. Eur Child Adolesc Psychiatry 1997; 6(Suppl 1):8-10.
4. Philippart M, Giudici TA: Low plasma carnitine in Rett syndrome, abstract. Neurology 1989;38(Suppl 1):294.
5. Tein I, De Vivo DC, Ranucci D, et al: Skin fibroblast carnitine uptake in secondary carnitine deficiency disorders. J Inherit Metab Dis 1993;6:135-146.
6. Plioplys AV, Kasnicka I: L-carnitine as a treatment for Rett syndrome. South Med J 1993;86:1411-1412.
7. Plochl E, Sperl W, Wermuth B, et al: Carnitine deficiency and carnitine therapy in a patient with Rett syndrome. Klin Padiatr 1996;208:129-134.
8. Breningstall GN: Carnitine deficiency states. Pediatr Neurol 1990; 6:75-81.
9. Eeg-Olofsson O, al-Zuhair AG, Teebi AS, et al: Rett syndrome: A mitochondrial disease? J Child Neurol 1990;5:210-214.
10. Dotti MT, Manneschi L, Malandrini A, et al: Mitochondrial dysfunction in Rett syndrome. An ultrastructural and biochemical study. Brain Dev 1993;15:103-106.
11. Coker SB, Melnyk AR: Rett syndrome and mitochondrial enzyme deficiencies. J Child Neurol 1991;6:164-166.
12. Tang J, Qi Y, Bao X, et al: Mutational analysis of mitochondrial DNA of children with Rett syndrome. Pediatr Neurol 1997;17:327-330.
13. The Rett Syndrome Diagnostic Working Group: Diagnostic criteria for Rett syndrome. Ann Neurol 1988;23:425-428.
14. Hagberg B, Witt-Engerstrom I: Rett syndrome: A suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet 1986;24:47-59.
15. FitzGerald PM, Jankovic J, Percy AK: Rett syndrome and associated movement disorders. Mov Disord 1990;5:195-202.
16. Burd L, Cook J, Randall T: The hand apraxia scale. Percept Mot Skills 1990;70:219-224.
17. Freeman JM, Vining EPG, Cost S, et al: Does carnitine improve the symptoms attributed to anticonvulsant medications? A double blinded crossover trial. Pediatrics 1994;93:893-895.
18. Hagberg BA, Skjeldal OH: Rett variants: A suggested model for inclusion criteria. Pediatr Neurol 1994;11:5-11.
19. Dean AG, Dean JA, Coulombier D, et al: EPIINFO, version 6: A word processing database and statistics program for epidemiology on microcomputers. Atlanta, Centers for Disease Control, 1994.
20. Christodoulou J, Teo SH, Hammond J, et al: First prenatal diagnosis of the carnitine transporter defect. Am J Med Genet 1996; 66:21-24.